AmerisourceBergen unit to plead guilty in U.S. in $260 mln settlement


An AmerisourceBergen Corp unit will plead guilty on Wednesday to a misdemeanor and pay $260 million to resolve a U.S. probe into a pre-filled syringe program operated by a unit of the company that ceased operations in 2014. AmerisourceBergen Specialty Group is scheduled to appear in federal court in Brooklyn for a plea hearing.



from Biotech News